Adma Biologics Income Statement (2011-2026)

Reported Financials

Adma Biologics Quarterly Income Statement

Periods 54 quarters

Latest Sep 2026

Adma Biologics reported revenue of $141.10M and net income of $49.88M for the quarter ended Sep 2026, up 5.1% year over year. This income statement covers 54 quarters of results from Mar 2011 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Revenue & cost
Revenue	26.38M	29.10M	33.91M	41.09M	49.98M	56.91M	60.12M	67.28M	73.90M	81.88M	107.19M	119.84M	117.55M	114.80M	121.98M	134.22M	139.16M	114.49M	124.40M	141.10M
Cost of RevenueCost of Rev	22.87M	25.44M	26.14M	31.43M	35.80M	40.40M	43.43M	42.62M	42.82M	42.77M	49.74M	60.18M	54.22M	53.71M	54.76M	58.60M	50.35M	33.74M	38.12M	41.19M
Gross Profit	3.51M	3.66M	7.77M	9.66M	14.18M	16.51M	16.69M	24.65M	31.09M	39.11M	57.45M	59.66M	63.33M	61.10M	67.23M	75.63M	88.82M	80.75M	86.28M	99.92M
Operating items
Amortization - Intangibles	0.18M	0.20M	0.20M	0.20M	0.18M	0.20M	0.20M	0.20M	0.19M	0.19M	0.14M	0.03M	0.03M	0.03M	0.03M	0.04M	0.05M	0.06M	0.06M	0.06M
Research & DevelopmentR&D	0.73M	0.62M	0.87M	1.04M	1.07M	0.86M	1.40M	0.60M	0.45M	0.45M	0.56M	0.41M	0.39M	0.83M	1.03M	1.53M	1.38M	2.60M	6.01M	4.49M
Selling, General & AdministrativeSG&A	11.70M	13.70M	11.97M	12.89M	13.89M	14.51M	14.25M	14.73M	15.54M	15.64M	16.61M	18.56M	23.32M	24.08M	22.21M	21.78M	23.51M	26.74M	26.74M	26.56M
Other Operating ExpensesOther Opex	4.10M	3.97M	3.92M	4.86M	5.09M	1.78M	0.70M	0.47M	0.69M	1.01M	0.94M	1.02M	1.28M	1.29M	1.15M	1.27M	1.13M	1.06M	1.03M	1.06M
Operating ExpensesOpex	16.70M	18.48M	16.94M	18.97M	20.24M	17.33M	17.16M	15.97M	16.85M	17.29M	18.25M	20.02M	25.01M	26.22M	24.43M	24.61M	26.07M	22.48M	33.83M	32.16M
Operating IncomeOp. Inc	-13.19M	-14.82M	-9.17M	-9.32M	-6.06M	-0.81M	-0.47M	8.69M	14.23M	21.82M	39.20M	39.64M	38.32M	34.88M	42.80M	51.01M	62.75M	58.27M	52.45M	67.76M
Non-operating items
Non Operating Interest Expenses	3.32M	3.39M	4.57M	5.58M	5.74M	6.12M	6.30M	6.40M	6.22M	3.77M	3.78M	3.50M	2.88M	1.98M	1.83M	1.68M	1.63M	2.10M	3.42M	3.43M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales																		7.98M
Interest & Investment IncomeInt & Inv Inc	0.00M	0.03M	0.00M	0.01M	0.00M	0.17M	0.41M	0.42M	0.61M	0.38M	0.45M	0.67M	0.60M	0.61M	0.40M	0.38M	0.49M	1.09M	1.24M	1.30M
Other Non Operating IncomeOther Non Op Inc.	-0.15M	-6.84M	-0.02M	-0.01M	-0.44M	-0.03M	-0.01M	-0.15M	-26.28M	-0.04M	-0.02M	-0.06M	-1.33M	-0.06M	-1.27M	-2.20M	-0.02M	-0.14M	-0.02M	-0.02M
Non Operating IncomeNon Op. Inc.	-3.46M	-10.19M	-4.59M	-5.58M	-6.17M	-5.98M	-5.90M	-6.12M	-31.88M	-3.42M	-3.35M	-2.89M	-3.61M	-1.43M	-2.70M	-3.50M	-1.16M	-1.15M	-2.21M	-2.15M
Net income details
EBIT	-13.19M	-14.82M	-9.17M	-9.32M	-6.06M	-0.81M	-0.47M	8.69M	14.23M	21.82M	39.20M	39.64M	38.32M	34.88M	42.80M	51.01M	62.75M	58.27M	52.45M	67.76M
EBT	-16.50M	-18.17M	-13.75M	-14.89M	-11.79M	-6.79M	-6.37M	2.57M	-17.65M	18.40M	35.85M	36.75M	34.71M	33.45M	40.10M	47.52M	61.60M	57.13M	50.24M	65.60M
Tax ProvisionsTaxes										0.60M	3.79M	0.84M	-77.18M	6.55M	5.88M	11.09M	12.22M	11.80M	12.42M	15.72M
Income After Tax	-16.50M	-18.17M	-13.75M	-14.89M	-11.79M	-6.79M	-6.37M	2.57M	-17.65M	17.81M	32.06M	35.91M	111.90M	26.90M	34.22M	36.43M	49.38M	45.33M	37.82M	49.88M
Income from Continuing OperationsIncome (Continuing)	-16.50M	-18.17M	-13.75M	-14.89M	-11.79M	-6.79M	-6.37M	2.57M	-17.65M	17.81M	32.06M	35.91M	111.90M	26.90M	34.22M	36.43M	49.38M	45.33M	37.82M	49.88M
Consolidated Net IncomeConsol Net Inc.	-16.50M	-18.17M	-13.75M	-14.89M	-11.79M	-6.79M	-6.37M	2.57M	-17.65M	17.81M	32.06M	35.91M	111.90M	26.90M	34.22M	36.43M	49.38M	45.33M	37.82M	49.88M
Income towards Parent CompanyParent Net Inc	-16.65M	-25.01M	-13.76M	-14.90M	-12.23M	-6.79M	-6.37M	2.57M	-17.65M	17.81M	32.06M	35.91M	111.90M	26.90M	34.22M	36.43M	49.38M	45.33M	37.82M	49.88M
Net Income towards Common StockholdersNet Income	-16.65M	-25.01M	-13.76M	-14.90M	-12.23M	-6.79M	-6.37M	2.57M	-17.65M	17.81M	32.06M	35.91M	111.90M	26.90M	34.22M	36.43M	49.38M	45.33M	37.82M	49.88M
Additional items
EPS (Basic)	-0.12	-0.13	-0.07	-0.08	-0.06	-0.03	-0.03	0.01	-0.08	0.08	0.14	0.15	0.48	0.11	0.14	0.15	0.21	0.19	0.17	0.22
EPS (Diluted)	-0.12	-0.13	-0.07	-0.08	-0.06	-0.03	-0.03	0.01	-0.08	0.08	0.13	0.15	0.46	0.11	0.14	0.15	0.20	0.19	0.16	0.22
Shares Outstanding	139.58M	195.87M	196.35M	196.38M	197.87M	221.92M	222.68M	225.28M	223.98M	228.87M	232.42M	234.57M	233.08M	237.78M	241.49M	238.60M	238.30M	236.07M	228.23M	223.70M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)	139.58M	195.87M	196.35M	196.38M	197.87M	221.92M	222.68M	233.76M	223.98M	236.41M	242.17M	244.80M	243.34M	244.68M	248.61M	244.66M	244.90M	239.96M	230.34M	225.82M
Shares Outstanding (Entity)Shares Outstanding (Entity.)	139.58M	196.35M	196.36M	196.78M	221.82M	222.26M	224.53M	225.96M	226.06M	231.77M	233.03M	236.38M	236.62M	238.53M	238.57M	238.33M	237.87M	232.29M	225.36M	222.79M
EBITDA	-11.17M	-12.64M	-7.11M	-6.47M	-3.63M	1.71M	2.31M	11.50M	17.04M	24.19M	41.48M	41.83M	40.49M	37.04M	45.02M	53.21M	64.99M	60.30M	54.42M	69.75M
Interest ExpensesInt Expense	3.32M	3.39M	4.57M	5.58M	5.74M	6.12M	6.30M	6.40M	6.22M	3.77M	3.78M	3.50M	2.88M	1.98M	1.83M	1.68M	1.63M	2.10M	3.42M	3.43M
Tax Rate										3.23%	10.57%	2.29%		19.57%	14.66%	23.33%	19.83%	20.65%	24.71%	23.96%

Adma Biologics Income Statement API

Pull Adma Biologics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADMA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "ADMA", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=ADMA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Adma Biologics ADMA Income Statement (2011-2026)

Adma Biologics Quarterly Income Statement

Adma Biologics Income Statement API

Create an account

Sign In

Reset Password